Emergo Therapeutics
PrivateLast Round
VC Round
Apr 26, 2022
Total Funding Raised
$12.58M
Company Overview
Emergo Therapeutics operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a VC Round in April 2022.
Emergo Therapeutics is a pharmaceutical company that develops drugs to modulate inflammatory responses for indications such as influenza-like illness and Long COVID.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Emergo Therapeutics Comparables
Compare Emergo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PridCor Therapeutics | 75% | |
| AIM ImmunoTech Inc. | 70% | |
| Romark Laboratories, L.C. | 69% |
For institutional investors. Book with your work email.
Emergo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 26, 2022 | ||||
| VC Round | Oct 12, 2020 | ||||
| Debt | Oct 1, 2019 | ||||
| Series A | May 23, 2018 | ||||
| Debt | Aug 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Emergo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Carolina Angel Network | Series A |
| North Carolina Biotechnology Center | Debt |
| Wolfpack Investor Network | Series A |
| Rex Health Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 310% MoM.
- May 2, 2025
Monthly visitors increased 128% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
Emergo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Emergo Therapeutics's valuation, stock price, and market status.
Is Emergo Therapeutics a public or private company?
Emergo Therapeutics is a private company.
What is the current stock price of Emergo Therapeutics?
Emergo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Emergo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Emergo Therapeutics worth (valuation)?
Valuation information for Emergo Therapeutics is not publicly available.
Can I buy Emergo Therapeutics stock?
Emergo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Emergo Therapeutics's last funding round?
Emergo Therapeutics's most recent funding round was VC Round on April 26, 2022.
Who are the main investors in Emergo Therapeutics?
Key investors in Emergo Therapeutics include North Carolina Biotechnology Center, Rex Health Ventures.
Will Emergo Therapeutics IPO soon?
No public IPO plans have been announced for Emergo Therapeutics.
How can I track Emergo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Emergo Therapeutics's shares on secondary markets.